504467 L-CCG-I - CAS 117857-93-9 - Calbiochem

504467
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Empirical FormulaCAS #
C₆H₉NO₄ 117857-93-9

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
5.04467.0001
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 5 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA potent agonist for group II metabotropic glutamate receptors (EC50 = 0.49 µM and 0.44 µM for mGlu2 and mGlu3, respectively). Higher level of activity than glutamate or (±)-trans-ACPD. Widely used in studies related to neurotransmissions mediated via group II mGlu receptors.
      Catalogue Number504467
      Brand Family Calbiochem®
      References
      ReferencesShinozaki, H., et al. 1989. Br. J. Pharmacol. 98, 1213.
      Hayashi, Y., et al. 1992. Br. J. Pharmacol. 107, 539.
      Nakanishi,S. 1992. Science. 258, 597.
      Watkins, J., et al. 1994. Trends Pharmacol Sci. 15, 333.
      Schoepp, D.D., et al. 1999. Neuropharmacology. 38, 1431.
      Product Information
      CAS number117857-93-9
      FormWhite solid
      Hill FormulaC₆H₉NO₄
      Chemical formulaC₆H₉NO₄
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetmGlu₂ & mGlu₃
      Purity≥97% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      L-CCG-I - CAS 117857-93-9 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      References

      Reference overview
      Shinozaki, H., et al. 1989. Br. J. Pharmacol. 98, 1213.
      Hayashi, Y., et al. 1992. Br. J. Pharmacol. 107, 539.
      Nakanishi,S. 1992. Science. 258, 597.
      Watkins, J., et al. 1994. Trends Pharmacol Sci. 15, 333.
      Schoepp, D.D., et al. 1999. Neuropharmacology. 38, 1431.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-September-2013 JSW
      DescriptionA potent agonist for group II metabotropic glutamate receptors (EC50 = 0.49 µM and 0.44 µM for mGlu2 and mGlu3, respectively). Higher level of activity than glutamate or (±)-trans-ACPD. Widely used in studies related to neurotransmissions mediated via group II mGlu receptors.
      FormWhite solid
      CAS number117857-93-9
      Chemical formulaC₆H₉NO₄
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityAqueous basic solutions
      Storage +2°C to +8°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesShinozaki, H., et al. 1989. Br. J. Pharmacol. 98, 1213.
      Hayashi, Y., et al. 1992. Br. J. Pharmacol. 107, 539.
      Nakanishi,S. 1992. Science. 258, 597.
      Watkins, J., et al. 1994. Trends Pharmacol Sci. 15, 333.
      Schoepp, D.D., et al. 1999. Neuropharmacology. 38, 1431.